Abstract
Diagnosis and Treatment1 June 1972Recommended Treatment Schedules for GonorrheaVENEREAL DISEASES BRANCH, STATE AND COMMUNITY SERVICES DIVISION, CENTER FOR DISEASE CONTROLVENEREAL DISEASES BRANCH, STATE AND COMMUNITY SERVICES DIVISION, CENTER FOR DISEASE CONTROLSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-76-6-991 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe preferred drug for Neisseria gonorrhoeae infection is penicillin or ampicillin. Physicians are cautioned to use no less than the recommended doses of antibiotics.For Treatment of Uncomplicated Gonorrhea (Urethral, Cervical, Pharyngeal, or Rectal)PARENTERALMen or women: aqueous procaine penicillin G, 4.8 million units intramuscularly divided into at least two doses and injected at different sites at one visit, together with 1 g of oral probenecid, preferably given at least 30 minutes before the injection.ORALMen or women: ampicillin, 3.5 g, with probenecid, 1 g, administered simultaneously.Treatment of ContactsPatients with known exposure to gonorrhea should receive... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Atlanta, Georgia▸Released in Morbidity and Mortality Weekly Report, 11 March 1972. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byMale urethritis in King County, Washington, 1974-75: II. Diagnosis and treatment.Gonococcal and Nongonococcal Urethritis in Men Clinical and Laboratory DifferentiationNORMAN F. JACOBS Jr., M.D., STEPHEN J. KRAUS, M.D.Single Oral Dose of Ampicillin-Probenicid as Gonorrhoea Treatment: Antibiotic Levels in Urethral ExudateInfectious diseases: annual review of significant publications. 1 June 1972Volume 76, Issue 6Page: 991-991KeywordsAntibioticsDrugsGonorrheaMorbidityMortalityPenicillin Issue Published: 1 June 1972 PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.